MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.

Volume 6 (2009), Issue 8 (August)

1. Lemierre's syndrome: methicillin-resistant Staphylococcus aureus (MRSA) finds a new home.
   J Emerg Med, 37(2): 131-4. [Abstract] [Full-text]
2. Staphylococcus aureus clfB and spa alleles of the repeat regions are segregated into major phylogenetic lineages.
   Infect Genet Evol, 9(5): 941-7. [Abstract] [Full-text]
3. Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Latin America.
   Int J Antimicrob Agents, 34(4): 304-8. [Abstract] [Full-text]
4. Videothoracoscopy in pleural empyema following methicillin-resistant Staphylococcus aureus (MRSA) lung infection.
   ScientificWorldJournal, 9: 723-8. [Abstract] [Full-text]
5. Mobile genetic element-encoded cytolysin connects virulence to methicillin resistance in MRSA.
   PLoS Pathog, 5(7): e1000533. [Abstract] [Full-text]
6. Antimicrobial gold nanorods with dual-modality photodynamic inactivation and hyperthermia.
   Chem Commun (Camb). [Abstract] [Full-text]
7. Impact of sarA on daptomycin susceptibility of Staphylococcus aureus biofilms in vivo.
   Antimicrob Agents Chemother. [Abstract] [Full-text]
8. In Vitro Bactericidal Activity of Iclaprim in Human Plasma.
   Antimicrob Agents Chemother. [Abstract] [Full-text]
9. Benzalkonium chloride enhances antibacterial activity of gatifloxacin and reduces its propensity to select for fluoroquinolone-resistant strains.
   J Ocul Pharmacol Ther, 25(4): 329-34. [Abstract] [Full-text]
10. In vitro antimicrobial activity of alpha-melanocyte stimulating hormone against major human pathogen Staphylococcus aureus.
    Peptides, 30(9): 1627-35. [Abstract] [Full-text]
11. Active surveillance for methicillin-resistant Staphylococcus aureus in the neonatal intensive care unit.
    Infect Control Hosp Epidemiol, 30(9): 854-60. [Abstract] [Full-text]
12. Relationship between the prevalence of methicillin-resistant Staphylococcus aureus infection and indicators of nosocomial infection control measures: a population-based study in French hospitals.
    Infect Control Hosp Epidemiol, 30(9): 861-9. [Abstract] [Full-text]
13. Cost-Effectiveness of daptomycin versus vancomycin and gentamicin for patients with methicillin-resistant Staphylococcus aureus bacteremia and/or endocarditis.
    Clin Infect Dis, 49(5): 691-8. [Abstract] [Full-text]
14. Control of healthcare-associated Staphylococcus aureus: Survey of practices in North Carolina hospitals.
    Infect Control Hosp Epidemiol, 30(9): 909-11. [Abstract] [Full-text]
15. Methicillin-resistant Staphylococcus aureus colonization of house officers.
    Infect Control Hosp Epidemiol, 30(9): 912-4. [Abstract] [Full-text]
16. Comparison of genotypes and enterotoxin genes between Staphylococcus aureus isolates from blood and nasal colonizers in a Korean hospital.
    J Korean Med Sci, 24(4): 585-91. [Abstract] [Full-text]
17. Design, Synthesis, and Structure-Activity Relationships of Benzophenone-Based Tetraamides as Novel Antibacterial Agents.
    J Med Chem. [Abstract] [Full-text]
18. Infective endocarditis in hemodialysis patients: clinical features, echocardiographic data and outcome: a 10-year descriptive analysis.
    Clin Exp Nephrol, 13(4): 350-4. [Abstract] [Full-text]
19. A point mutation in the agr locus rather than expression of the Panton-Valentine leukocidin caused previously reported phenotypes in Staphylococcus aureus pneumonia and gene regulation.
    J Infect Dis, 200(5): 724-34. [Abstract] [Full-text]
20. Carriage of methicillin-resistant Staphylococcus aureus in veterinary personnel.
    Epidemiol Infect, 137(9): 1233-6. [Abstract] [Full-text]
21. Report of a hospital neonatal unit outbreak of community-associated methicillin-resistant Staphylococcus aureus.
    Epidemiol Infect, 137(9): 1242-8. [Abstract] [Full-text]
22. Prevalence of community-associated methicillin-resistant Staphylococcus aureus colonization outside the healthcare environment.
    Epidemiol Infect, 137(9): 1237-41. [Abstract] [Full-text]
23. Epidemiology of community-onset Staphylococcus aureus infections in pediatric patients: an experience at a Children's Hospital in central Illinois.
    BMC Infect Dis, 9: 112. [Abstract] [Full-text]
24. Report from the 67th Annual Meeting of the American Academy of Dermatology.
    Br J Dermatol. [Abstract] [Full-text]
25. A prevalence screen of MRSA nasal colonisation amongst UK doctors in a non-clinical environment.
    Eur J Clin Microbiol Infect Dis, 28(8): 991-5. [Abstract] [Full-text]
26. Rapid detection of Staphylococcus aureus bacteremia and methicillin resistance by real-time PCR in whole blood samples.
    Eur J Clin Microbiol Infect Dis, 28(8): 1001-5. [Abstract] [Full-text]
27. Prevalence of Panton-Valentine leukocidin genes in methicillin-resistant Staphylococcus aureus isolates phenotypically consistent with community-acquired MRSA, 1999-2007, Vienna General Hospital.
    Eur J Clin Microbiol Infect Dis, 28(8): 909-12. [Abstract] [Full-text]
28. Clinical features and treatment outcomes of vancomycin-intermediate Staphylococcus aureus (VISA) and heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) in a tertiary care institution in Singapore.
    Eur J Clin Microbiol Infect Dis, 28(8): 983-7. [Abstract] [Full-text]
29. Anti-microbial activities of pomegranate rind extracts: enhancement by cupric sulphate against clinical isolates of S. aureus, MRSA and PVL positive CA-MSSA.
    BMC Complement Altern Med, 9: 23. [Abstract] [Full-text]
30. Antibiotic considerations in the treatment of multidrug-resistant (MDR) pathogens: A case-based review.
    J Hosp Med, 4(6): E8-E15. [Abstract] [Full-text]
31. Carriage of methicillin-resistant Staphylococcus aureus in home care settings: prevalence, duration, and transmission to household members.
    Arch Intern Med, 169(15): 1372-8. [Abstract] [Full-text]
32. Severe soft tissue infections.
    Infect Dis Clin North Am, 23(3): 571-91. [Abstract] [Full-text]
33. A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species.
    J Antimicrob Chemother, 64(3): 546-51. [Abstract] [Full-text]
34. Establishment of an outpatient and home parenteral antimicrobial therapy service at a London teaching hospital: a case series.
    J Antimicrob Chemother, 64(3): 630-4. [Abstract] [Full-text]
35. High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection.
    J Antimicrob Chemother, 64(3): 574-8. [Abstract] [Full-text]
36. Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology.
    J Antimicrob Chemother, 64(3): 441-6. [Abstract] [Full-text]
37. Characteristics of community- and hospital-acquired meticillin-resistant Staphylococcus aureus strains carrying SCCmec type IV isolated in Malaysia.
    J Med Microbiol, 58: 1213-8. [Abstract] [Full-text]
38. Characterization of meticillin-resistant Staphylococcus aureus isolates from hospitals in KwaZulu-Natal province, Republic of South Africa.
    J Med Microbiol, 58: 1219-26. [Abstract] [Full-text]
39. Distribution of meticillin-resistant Staphylococcus aureus spa types isolated from health-care workers and patients in a Scottish university teaching hospital.
    J Med Microbiol, 58: 1190-5. [Abstract] [Full-text]
40. Central nervous system invasion by community-acquired meticillin-resistant Staphylococcus aureus.
    J Med Microbiol, 58: 1247-51. [Abstract] [Full-text]
41. Rapid detection of methicillin-resistant Staphylococcus aureus directly from clinical samples: methods, effectiveness and cost considerations.
    Ger Med Sci, 7: Doc06. [Abstract] [Full-text]
42. Emergence of community-associated methicillin-resistant Staphylococcus aureus associated with pediatric infection in Cambodia.
    PLoS One, 4(8): e6630. [Abstract] [Full-text]
43. The changing epidemiology of resistance.
    J Antimicrob Chemother, 64: i3-10. [Abstract] [Full-text]
44. Has the era of untreatable infections arrived?
    J Antimicrob Chemother, 64: i29-36. [Abstract] [Full-text]
45. Antimicrobial resistance in the UK and Ireland.
    J Antimicrob Chemother, 64: i19-23. [Abstract] [Full-text]
46. Voluntary and mandatory surveillance for methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) bacteraemia in England.
    J Antimicrob Chemother, 64: i11-7. [Abstract] [Full-text]
47. Successful salvage therapy with daptomycin after linezolid and vancomycin failure in a liver transplant recipient with methicillin-resistant Staphylococcus aureus endocarditis.
    Transpl Infect Dis, 11(4): 346-8. [Abstract] [Full-text]
48. Incidence and risk factors for ventilator-associated pneumonia after major heart surgery.
    Intensive Care Med, 35(9): 1518-25. [Abstract] [Full-text]
49. Waves of resistance: Staphylococcus aureus in the antibiotic era.
    Nat Rev Microbiol, 7(9): 629-41. [Abstract] [Full-text]
50. Trichogin GA IV: an antibacterial and protease-resistant peptide.
    J Pept Sci, 15(9): 615-9. [Abstract] [Full-text]
51. Change in environmental bacterial flora in a new hospital building.
    J Hosp Infect, 73(1): 24-33. [Abstract] [Full-text]
52. Methicillin and aminoglycoside resistance in Staphylococcus aureus isolates from bovine mastitis and sequence analysis of their mecA genes.
    Vet Res Commun. [Abstract] [Full-text]
53. Occurrence of methicillin-resistant Staphylococcus aureus in rats living on pig farms.
    Prev Vet Med, 91(2): 270-3. [Abstract] [Full-text]
54. Comparative evaluation of a rapid MRSA detection assay based on multiplex real-time PCR versus MRSA screening cultures containing egg yolk.
    J Infect Chemother, 15(4): 262-5. [Abstract] [Full-text]
55. Staphylococcus aureus Nasal Colonization Among Pediatric CF Patients and Their Household Contacts.
    Pediatr Infect Dis J. [Abstract] [Full-text]
56. Stevens-Johnson syndrome and toxic epidermal necrolysis: consequence of treatment of an emerging pathogen.
    Pediatr Emerg Care, 25(8): 519-22. [Abstract] [Full-text]
57. Staphylococcus aureus in the community: colonization versus infection.
    PLoS One, 4(8): e6708. [Abstract] [Full-text]
58. Mupirocin resistance.
    Clin Infect Dis, 49(6): 935-41. [Abstract] [Full-text]
59. Epidemiology of dermatitis and skin infections in United States physicians' offices, 1993-2005.
    Clin Infect Dis, 49(6): 901-7. [Abstract] [Full-text]
60. Delivery of Methylene Blue and meso-tetra (N-methyl-4-pyridyl) porphine tetra tosylate from cross-linked poly(vinyl alcohol) hydrogels: a potential means of photodynamic therapy of infected wounds.
    J Photochem Photobiol B, 96(3): 223-31. [Abstract] [Full-text]
61. Rapid screening tests for meticillin-resistant Staphylococcus aureus at hospital admission: systematic review and meta-analysis.
    Lancet Infect Dis, 9(9): 546-54. [Abstract] [Full-text]
62. Search and destroy policy for methicillin-resistant Staphylococcus aureus: cost-benefit analysis.
    J Adv Nurs, 65(9): 1853-9. [Abstract] [Full-text]
63. Prevalence of methicillin-resistant Staphylococcus aureus in meat.
    Int J Food Microbiol, 134(1): 52-6. [Abstract] [Full-text]
64. The fate of acute methicillin-resistant Staphylococcus aureus periprosthetic knee infections treated by open debridement and retention of components.
    J Arthroplasty, 24(6): 101-4. [Abstract] [Full-text]
65. Factors affecting health care workers' adoption of a website with infection control guidelines.
    Int J Med Inform, 78(10): 663-78. [Abstract] [Full-text]
66. A mapping of drug space from the viewpoint of small molecule metabolism.
    PLoS Comput Biol, 5(8): e1000474. [Abstract] [Full-text]
67. Excretion of antimicrobials used to treat methicillin-resistant Staphylococcus aureus infections during lactation: safety in breastfeeding infants.
    Pharmacotherapy, 29(9): 1103-9. [Abstract] [Full-text]
68. Purification and characterization of a new L-amino acid oxidase from Daboia russellii siamensis venom.
    Toxicon, 54(6): 763-71. [Abstract] [Full-text]
69. Surgical site infections: does inadequate antibiotic therapy affect patient outcomes?
    Surg Infect (Larchmt), 10(4): 323-31. [Abstract] [Full-text]
70. Synthesis and antibacterial activity of a series of alpha-substituted acetylpiperazinyl oxazolidinones.
    Chem Biol Drug Des, 74(3): 276-81. [Abstract] [Full-text]
71. Clinical challenges in addressing resistance to antimicrobial drugs in the twenty-first century.
    Clin Pharmacol Ther, 86(3): 336-9. [Abstract] [Full-text]
72. Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13.
    PLoS One, 4(8): e6788. [Abstract] [Full-text]
73. Design, conduct, and analysis of clinical trials in disease due to methicillin-resistant Staphylococcus aureus.
    Clin Pharmacol Ther, 86(3): 244-7. [Abstract] [Full-text]
74. Cycloartane triterpenes from dikamali, the gum resin of Gardenia gummifera and Gardenia lucida.
    Chem Biodivers, 6(8): 1185-92. [Abstract] [Full-text]
75. 5-(2-Pyrimidinyl)-imidazo[1,2-a]pyridines are antibacterial agents targeting the ATPase domains of DNA gyrase and topoisomerase IV.
    Bioorg Med Chem Lett, 19(18): 5302-6. [Abstract] [Full-text]
76. Water-soluble phosphate prodrugs of pleuromutilin analogues with potent in vivo antibacterial activity against Gram-positive pathogens.
    Bioorg Med Chem Lett, 19(18): 5407-10. [Abstract] [Full-text]
77. Antibacterial activity of sophoraflavanone G Isolated from the roots of Sophora flavescens against methicillin-resistant Staphylococcus aureus.
    Phytother Res, 23(9): 1326-31. [Abstract] [Full-text]
78. Nasal colonization of humans with methicillin-resistant Staphylococcus aureus (MRSA) CC398 with and without exposure to pigs.
    PLoS One, 4(8): e6800. [Abstract] [Full-text]
79. Prevalence of nasal carriage of methicillin-resistant Staphylococcus aureus and its antibiotic susceptibility pattern in healthcare workers at Namazi Hospital, Shiraz, Iran.
    Int J Infect Dis, 13(5): e241-7. [Abstract] [Full-text]
80. Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins.
    Appl Environ Microbiol, 75(17): 5451-60. [Abstract] [Full-text]
81. Optical mapping reveals a large genetic inversion between two methicillin-resistant Staphylococcus aureus strains.
    J Bacteriol, 191(18): 5717-23. [Abstract] [Full-text]
82. Scalarane sesterterpenoids: semisynthesis and biological activity.
    J Nat Prod, 72(8): 1492-6. [Abstract] [Full-text]
83. Antibiotics for emerging pathogens.
    Science, 325(5944): 1089-93. [Abstract] [Full-text]
84. Mycotic ascending aortic pseudoaneurysm at aortic cannulation site.
    Asian Cardiovasc Thorac Ann, 17(4): 417-8. [Abstract] [Full-text]
85. Polymerase chain reaction screening for methicillin-resistant Staphylococcus aureus and contact isolation.
    Am J Infect Control, 37(7): 601-2. [Abstract] [Full-text]
86. Survival of Staphylococcus and other bacteria in skin prick test antigens solutions.
    Am J Infect Control, 37(7): 606-8. [Abstract] [Full-text]
87. The diabetic foot clinic: not a significant source for acquisition of methicillin-resistant Staphylococcus aureus.
    Am J Infect Control, 37(7): 587-9. [Abstract] [Full-text]
88. Risk factors associated with methicillin-resistant Staphylococcus aureus colonization on hospital admission among oncology patients.
    Am J Infect Control, 37(7): 603-5. [Abstract] [Full-text]
89. Population pharmacokinetic analysis of linezolid in patients with infectious disease: application to lower body weight and elderly patients.
    J Clin Pharmacol, 49(9): 1071-8. [Abstract] [Full-text]
90. An investigation of the risk factors for infection with methicillin-resistant Staphylococcus aureus among patients in a neonatal intensive care unit.
    Am J Infect Control, 37(7): 580-6. [Abstract] [Full-text]
91. The disruption of bacterial membrane integrity through ROS generation induced by nanohybrids of silver and clay.
    Biomaterials, 30(30): 5979-87. [Abstract] [Full-text]
92. Chemical genetic identification of peptidoglycan inhibitors potentiating carbapenem activity against methicillin-resistant Staphylococcus aureus.
    Chem Biol, 16(8): 837-48. [Abstract] [Full-text]
93. A pilot study to assess frequency of carriage and routes of acquisition of Staphylococcus aureus by healthy infants.
    Am J Infect Control, 37(7): 598-600. [Abstract] [Full-text]

© 2004-2012 MRSA Research Today. All Rights Reserved.